Polymorphisms and pancreatic cancer risk: A meta-analysis

European Journal of Cancer Prevention

Volumn 20, Issue 3, 2011, Pages 169-183

  Mazaki, Takero ^a   Masuda, Hideki ^a   Takayama, Tadatoshi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

meta analysis; pancreatic cancer; polymorphisms

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; GENE FUNCTION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; PANCREAS CANCER; PENETRANCE; PRIORITY JOURNAL; RACE DIFFERENCE; SAMPLE SIZE; SENSITIVITY ANALYSIS; SMOKING;

EID: 85027945612     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328344743a     Document Type: Article

References (49)

1. Barber MD, Powell JJ, Lynch SF, Fearon KC, Ross JA (2000). A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer. Br J Cancer 83:1443-1447.
2. Bartsch H, Malaveille C, Lowenfels AB, Maisonneuve P, Hautefeuille A, Boyle P; The International Pancreatic Disease Study Group (1998). Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. Eur J Cancer Prev 7:215-223. (Pubitemid 28318342)
3. Beranek H, Teich N, Witt H, Schulz HU, Mossner J, Keim V (2003). Analysis of tumour necrosis factor alpha and interleukin 10 promotor variants in patients with chronic pancreatitis. Eur J Gastroenterol Hepatol 15:1223-1227. (Pubitemid 38174848)
4. Chen J, Giovannucci EL, Hunter DJ (1999). MTHFR polymorphism, methylreplete diets and the risk of colorectal carcinoma and adenoma among US men and women: an example of gene-environment interactions in colorectal tumorigenesis. J Nutr 129 (2S Suppl):560S-564S (Pubitemid 29069669)
5. Collier JD, Bennett MK, Hall A, Cattan AR, Lendrum R, Bassendine MF (1994). Expression of glutathione S-transferases in normal and malignant pancreas: an immunohistochemical study. Gut 35:266-269. (Pubitemid 24092877)
6. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Controlled Clin Trials 7:177-188. (Pubitemid 17189972)
7. Duell EJ, Holly EA, Bracci PM,Wiencke JK, Kelsey KT (2002a). A population-based case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J Nat Cancer Instit 94:397-306.
8. Duell EJ, Holly EA, Bracci PM, Wiencke JK, Kelsey KT (2002b). A populationbased study of the Arg399Gln polymorphism in X-ray repair crosscomplementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res 62:4630-4636.
9. Duell EJ, Casella DP, Burk RD, Kelsey KT, Holly EA (2006). Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev 15:726-731.
10. Egger M, Smith GD, Altman DG (2001). Systematic review in health care. Metaanalysis in context. 2nd ed. London: BMJ Books.
11. Hardy GH (1908). Mendelian proportions in a mixed population. Science 28:49-50.
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ 327:557-560. (Pubitemid 37088507)
13. Hruban RH, Goggins M, Parsons J, Kern SE (2000). Progression model for pancreatic cancer. Clin Cancer Res 6:2969-2972. (Pubitemid 30637716)
14. Ioannidis JP, Trikalinos TA (2007). The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMJ 176:1091-1096. (Pubitemid 46649731)
15. Jiao L, Bondy ML, Hassan MM,Wolff RA, Evans DB, Abbruzzese JL, Li D (2006). Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. Cancer Detect Prev 30:284-291. (Pubitemid 44163055)
16. Jiao L, Doll MA, Hein DW, Bondy ML, Hassan MM, Hixson JE, et al. (2007a). Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 16:2379-2386. (Pubitemid 351196371)
17. Jiao L, Bondy ML, Hassan MM, Chang DZ, Abbruzzese JL, Evans DB, et al. (2007b). Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer. Cancer 109:840-848. (Pubitemid 46333525)
18. Kanda J, Matsuo K, Suzuki T, Kawase T, Hiraki A, Watanabe M, et al. (2008). Impact of alcohol consumption with polymorphisms in alcohol-metabolizing enzymes on pancreatic cancer risk in Japanese. Cancer Sci 100:296-302.
19. Kim YI (2005). Folate and methylenetetrahydrofolate reductase polymorphisms: new nutritional and genetic risk factors for pancreatic cancer? Clin Gastroenterol Hepatol 3:738-742.
20. Larsson SC, Giovannucci E, Wolk A (2006). Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 131:1271-1283. (Pubitemid 44515102)
21. Lee HC, Yoon YB, Kim CY (1997). Association between genetic polymorphisms of the cytochromes P-450 (1A1, 2D6, and 2E1) and the susceptibility to pancreatic cancer. Korean J Intern Med 12:128-136.
22. Lempinen M, Paju A, Kemppainen E, Smura T, Kylanpaa ML, Nevanlinna H, et al. (2005). Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: a report from Finland. Scand J Gastroenterol 40:225-230. (Pubitemid 40189003)
23. Lewis SJ, Smith GD (2005). Alcohol, ALDH2, and esophageal cancer: a metaanalysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev 14:1967-1971. (Pubitemid 41161208)
24. Li D, Xie K, Wolff R, Abbruzzese JL (2004). Pancreatic cancer. Lancet 363: 1049-1057. (Pubitemid 38410779)
25. Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA, et al. (2005). 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 14:1470-1476. (Pubitemid 40807348)
26. Li D, Jiao L, Li Y, Doll MA, Hein DW, Bondy ML, et al. (2006). Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis 27:103-111. (Pubitemid 43025249)
27. Liu G, Ghadirian P, Vesprini D, Hamel N, Paradis AJ, Lai G, et al. (2000). Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma. Br J Cancer 82:1646-1649. (Pubitemid 30229573)
28. Lowenfels AB, Maisonneuve P (2006). Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 20:197-209.
29. Matsubayashi H, Fukushima N, Sato N, Brune K, Canto M, Yeo CJ, et al. (2003). Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer. Cancer Biol Ther 2:652-655.
30. Matsubayashi H, Skinner HG, Iacobuzio-Donahue C, Abe T, Sato N, Riall TS, et al. (2005). Pancreaticobiliary cancers with deficient methylenetetrahydrofolate reductase genotypes. Clin Gastroenterol Hepatol 3:752-760. (Pubitemid 41116727)
31. Mazaki T, Ishii Y, Takayama T (2006). Meta-analysis of prophylactic antibiotic use in acute necrotizing pancreatitis. Brit J Surg 93:674-684. (Pubitemid 43886018)
32. McWilliams RR, Bamlet WR, Cunningham JM, Goode EL, de Andrade M, Boardman LA, Petersen GM (2008). Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 68:4928-4935.
33. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS (2001). Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev 10:429-437. (Pubitemid 32701627)
34. Miyasaka K, Kawanami T, Shimokata H, Ohta S, Funakoshi A (2005). Inactive aldehyde dehydrogenase-2 increased the risk of pancreatic cancer among smokers in a Japanese male population. Pancreas 30:95-98. (Pubitemid 40289446)
35. Ockenga J, Vogel A, Teich N, Keim V, Manns MP, Strassburg CP (2003). UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 124: 1802-1808. (Pubitemid 36666777)
36. Piepoli A, Gentile A, Valvano MR, Barana D, Oliani C, Cotugno R, et al. (2006). Lack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients. World J Gastroenterol 12:6343-6348. (Pubitemid 44712417)
37. Seitz HK, Stickel F (2007). Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7:599-612. (Pubitemid 47106631)
38. Sohn TA, Yeo CJ (2000). The molecular genetics of pancreatic ductal carcinoma: a review. Surg Oncol 9:95-101. (Pubitemid 32441861)
39. Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, Hartman TJ, Tangrea JA, Rautalahti M, et al. (1999). Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 91:535-541. (Pubitemid 29157062)
40. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F (2002). Methods for metaanalysis in medical research. West Sussex: John Wiley &Sons Ltd.
41. Suzuki T, Matsuo K, Sawaki A, Mizuno N, Hiraki A, Kawase T, et al. (2008). Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 17:2742-2747.
42. Teich N, Schulz HU, Witt H, Bohmig M, Keim V (2003). N34S, a pancreatitis associated SPINK1 mutation, is not associated with sporadic pancreatic cancer. Pancreatology 3:67-68. (Pubitemid 36351181)
43. Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, Duffy D, et al. (2005). Systematic review and meta-analysis of the association between b2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 162:201-211. (Pubitemid 41373524)
44. Verlaan M, Drenth JP, Truninger K, Koudova M, Schulz HU, Bargetzi M, et al. (2005). Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases. J Med Genet 42:e62.
45. Wang L, Miao X, Tan W, Lu X, Zhao P, Zhao X, et al. (2005). Genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase and risk of pancreatic cancer. Clin Gastroenterol Hepatol 3: 743-751. (Pubitemid 41116726)
46. Wang L, Lin DX, Lu XH, Miao XP, Li H (2006). Polymorphisms of the DNA repair genes XRCC1 and XPC: relationship to pancreatic cancer risk. J Hygiene Res 35:534-536.
47. Weinberg W. (1908). Uber den nachweis der Vererbung beim Menschen. Jahresh Wuertt Ver Vaterl Natkd [German] 64: 369-382.
48. Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Renlund M, et al. (2003). Geographical and ethnic variation of the 677C T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas worldwide. J Med Genet 40:619-625. (Pubitemid 37046918)
49. Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ, et al. (2000). Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 60:2002-2006. (Pubitemid 30207663)